Benjamin Edwards »

Crispr Therapeutics shares owned by Benjamin Edwards

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Benjamin Edwards from 13F filings

Historical chart of Benjamin Edwards investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Benjamin Edwards consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Benjamin Edwards

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 33k 46.98
2024-06-30 $13k 238 54.62
2024-03-31 $25k 369 67.75
2023-12-31 $21k 339 61.95
2023-09-30 $23k 504 45.63
2023-06-30 $28k 491 57.03
2023-03-31 $25k 558 44.80
2022-12-31 $21k 528 39.77
2022-09-30 $28k 421 66.51
2022-06-30 $30k 499 60.12
2022-03-31 $30k 480 62.50
2021-12-31 $36k 470 76.60
2021-09-30 $44k 396 111.11
2021-06-30 $66k 410 160.98
2021-03-31 $58k 478 121.34
2020-12-31 $83k 545 152.29
2020-09-30 $65k 778 83.55
2020-06-30 $54k 730 73.97
2020-03-31 $31k 730 42.47
2019-12-31 $38k 621 61.19
2019-09-30 $23k 567 40.56
2019-06-30 $26k 546 47.62
2019-03-31 $10k 278 35.97